Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Span of Spleen Is Associated With Disability Status in Multiple Sclerosis: A Cross-Sectional Abdominopelvic Ultrasonography Study
Masoud Etemadifar
Masoud Etemadifar

Professor of Neurology

Department of Neurosurgery, School of Medicine

Neurosciences Research Center

Al-Zahra Hospital

Isfahan University of Medical Sciences

All Documents
1. Assessment of Reliability and Validity of the Persian Version of the Parkinson’S Anxiety Scale (P-Pas), Applied Neuropsychology: Adult (2025)
2. Balo Concentric Sclerosis, an Emerging Variant of Multiple Sclerosis: A Case-Series and Literature Review, Journal of Neuroimmunology (2025)
3. Distal Median Nerve Dysfunction and Carpal Tunnel Syndrome in People With Multiple Sclerosis Treated With Teriflunomide: An Electrodiagnostic Study, Neurological Sciences (2025)
4. First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis, Neurotherapeutics (2025)
5. Headache in Radiologically Isolated Syndrome: A Hint Toward Imminent Conversion: A Case Report, Journal of Medical Case Reports (2025)
6. Pure Spinal Multiple Sclerosis: A Case Series of a Possible New Entity, Journal of Neuroimmunology (2025)
7. Supranuclear Vertical Gaze Palsy in Movement Disorders, Neuro-Ophthalmology (2025)
8. A Multi-Centre Longitudinal Study Analysing Multiple Sclerosis Disease-Modifying Therapy Prescribing Patterns During the Covid-19 Pandemic, Journal of Neurology (2024)
9. A Review of Ocular Movement Abnormalities in Hereditary Cerebellar Ataxias, Cerebellum (2024)
10. Abnormal Multisensory Temporal Discrimination in Parkinson's Disease, Brain Research (2024)
11. Anti-Cd20 Therapies for Pediatric-Onset Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2024)
12. Chorea Associated With Notch3 Gene Mutation, Movement Disorders Clinical Practice (2024)
13. Covid-19 in Parkinson's Disease Treated by Drugs or Brain Stimulation; [Covid-19 En La Enfermedad De Parkinson Tratada Con Farmacos O Estimulacion Cerebral], Neurologia (2024)
14. Dietary Approach to Stop Hypertension (Dash), But Not Mediterranean and Mind, Dietary Pattern Protects Against Parkinson's Disease, Food Science and Nutrition (2024)
15. Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies, Neurology: Neuroimmunology and NeuroInflammation (2024)
16. Elucidating the Role of a Shared Lncrna-Mirna-Mrna Network in Exacerbating Parkinson's Disease Symptoms in the Context of Covid-19 Infection, Gene Expression The Journal of Liver Research (2024)
17. Evaluation of Atrophy After Botulinum Toxin Injection in Cervical Dystonia by Mri, Neurology Asia (2024)
18. Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies, Journal of Neurology (2024)
19. Medication Adherence and Its Relationship With Self-Esteem Among Patients With Epilepsy in Isfahan, Iran, Epilepsy and Behavior (2024)
20. Multiple Sclerosis and Self-Alienation: A Study Based on Self and Others Representations, BMC Psychology (2024)
21. Optic Neuritis Following Covid-19 Vaccination: Case Series and Review of the Literature; [Nevrite Optique Apres Vaccination Contre La Covid-19: Serie De Cas Et Revue De La Litterature], Journal Francais d'Ophtalmologie (2024)
22. Positional Head Tremor in Professional Billiards Player, Acta Neurologica Belgica (2024)
23. Predictors of Relapse Risk and Treatment Response in Aqp4-Igg Positive and Seronegative Nmosd: A Multicentre Study, Journal of Neurology, Neurosurgery and Psychiatry (2024)
24. Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With Aqp4-Igg-Positive Nmosd, Neurology (2024)
25. Primary Hemifacial Spasm: Anatomical Insights, Acta Neurologica Belgica (2024)
26. Relapse-Independent Disease Activity in Neuromyelitis Optica Spectrum Disorder: A Systematic Review, Multiple Sclerosis and Related Disorders (2024)
27. Relative Frequency of Primary Headaches in Patients With Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study, Current Journal of Neurology (2024)
28. Risk of Depression After Parkinson's Disease, Stroke, Multiple Sclerosis, and Migraine in an Iranian Population and Assess Psychometric Characteristics of Three Prevalent Depression Questionnaires, IBRO Neuroscience Reports (2024)
29. Span of Spleen Is Associated With Disability Status in Multiple Sclerosis: A Cross-Sectional Abdominopelvic Ultrasonography Study, Scientific Reports (2024)
30. The Diagnostic Performance of Ai-Based Algorithms to Discriminate Between Nmosd and Ms Using Mri Features: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
31. The Effects of Laser Cane Cues on the Freezing of Gait of Parkinson’S Disease Patients: Can Increasing the Laser Light Beam Width Play a Role?, Acta Neurologica Belgica (2024)
32. The Prominence of Oligoclonal Bands for Clinical Conversion in Radiologically Isolated Syndrome: 10-Year Follow-Up Study in Isfahan, Iran, Clinical Neurology and Neurosurgery (2024)
33. Whole Spinal Transverse Myelitis in Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis and Related Disorders (2024)
34. A Case of Ercc6-Related Cockayne Syndrome Presenting With Levodopa-Responsive Tremor Syndrome, Movement Disorders Clinical Practice (2023)
35. A Review on Approach to a Twitchy Tongue in Neurology, Neurological Sciences (2023)
36. Balance Rehabilitation for Patients With Multiple Sclerosis Using a Kinect®-Based Virtual Training Program, Journal of Clinical Neuroscience (2023)
37. Coordinated Modification in Expression Levels of Hspa1a/B, Dgkh, and Notch2 in Parkinson’S Patients’ Blood and Substantia Nigra As a Diagnostic Sign: The Transcriptomes’ Relationship, Neurological Sciences (2023)
38. Diffuse Subcortical White Matter Restriction: An Uncommon Finding on Metronidazole Toxicity, Neuroradiology Journal (2023)
39. Effect of Multiple Sclerosis Disease-Modifying Therapies on the Real-World Effectiveness of Two Doses of Bbibp-Corv (Sinopharm) Vaccine, Journal of the Neurological Sciences (2023)
40. Evaluation of the Prevalence of Bovine Leukemia Virus Dna in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, IJID Regions (2023)
41. Evaluation of the Prevalence of Bovine Leukemia Virus Dna in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, IJID Regions (2023)
42. Human Exposure to Dust and Heavy Metals in Industrial Regions and Its Relationship With the Prevalence of Multiple Sclerosis Disease, Environmental Monitoring and Assessment (2023)
43. Longitudinal Extensive Transverse Myelitis Due to Tuberculosis: A Case Report, Neuroradiology Journal (2023)
44. Neuro-Mucormycosis: Lessons From Covid-19-Associated Cases, Current Journal of Neurology (2023)
45. Neurodegeneration, Ataxia, Dystonia, and Gaze Palsy (Nadgp) Syndrome With Nocturnal Paroxysmal Head Tremor, Movement Disorders Clinical Practice (2023)
46. Neuromuscular Electrical Stimulation in Conjunction With Conventional Swallowing Therapy in the Treatment of Dysphagia Caused by Multiple Sclerosis: A Single-Case Experimental Design, Folia Phoniatrica et Logopaedica (2023)
47. Non-Infectious Meningitis and Cns Demyelinating Diseases: A Conceptual Review, Revue Neurologique (2023)
48. Retracted Article: The Association of Interleukin-16 Gene Polymorphisms With Il-16 Serum Levels and Risk of Multiple Sclerosis, Immunological Investigations (2023)
49. Riboflavin and Histidine Metabolisms Are Two Key Pathways Related to the Clinically Isolated Syndrome (Cis): A Wgcna-Based in Silico Analysis, Current Pharmacogenomics and Personalized Medicine (2023)
50. Rituximab-Associated Pres in Antibody-Mediated Kidney Rejection: A Case Report, Transplant Immunology (2023)
51. Third Covid-19 Vaccine Dose for People With Multiple Sclerosis Who Did Not Seroconvert Following Two Doses of Bbibp-Corv (Sinopharm) Inactivated Vaccine: A Pilot Study on Safety and Immunogenicity, Frontiers in Immunology (2023)
52. Atherosclerosis and Multiple Sclerosis: An Overview on the Prevalence of Risk Factors, Multiple Sclerosis and Related Disorders (2022)
53. Autoimmune Encephalitis: The First Observational Study From Iran, Neurological Sciences (2022)
54. Barriers to Quality of Life in Patients With Multiple Sclerosis: A Qualitative Study, BMC Neurology (2022)
55. Centrally-Located Transverse Myelitis Would Facilitate the Differentiation of Nmosd and Mog-Ad From Ms, Multiple Sclerosis and Related Disorders (2022)
56. Detection of Anti-Nmda Receptor Antibodies Following Bbibp-Corv Covid-19 Vaccination in a Rituximab-Treated Person With Multiple Sclerosis Presenting With Manifestations of an Acute Relapse, Human Vaccines and Immunotherapeutics (2022)
57. Diagnosis and Classification of Optic Neuritis, The Lancet Neurology (2022)
58. Do Optic Neuritis Patients Report Their Visual Impairment More Frequently Upon Awakening?, International Journal of Neuroscience (2022)
59. Does Covid-19 Increase the Long-Term Relapsing-Remitting Multiple Sclerosis Clinical Activity? a Cohort Study, BMC Neurology (2022)
60. Evaluation of S100a12 and Apo-A1 Plasma Level Potency in Untreated New Relapsing–Remitting Multiple Sclerosis Patients and Their Family Members, Scientific Reports (2022)
61. Facial Involvement in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
62. Frequency of Diencephalic Syndrome in Nmosd, Acta Neurologica Belgica (2022)
63. Immunomodulatory Drug Fingolimod (Fty720) Restricts the Growth of Opportunistic Yeast Candida Albicans in Vitro and in a Mouse Candidiasis Model, PLoS ONE (2022)
64. Inducing Chimeric Antigen Receptor (Car) Regulatory T Cells In-Vivo: A Novel Concept for a Potential Feasible Cure of Demyelinating Diseases, Multiple Sclerosis and Related Disorders (2022)
65. Investigation of Resilience in Patients With Epilepsy Referred to Medical Centers in Isfahan in 2021, Jundishapur Journal of Chronic Disease Care (2022)
66. Limited Access to Health Care in Patients With Atypical Parkinsonism During Covid-19 Era May Lead to Higher Mortality, Current Journal of Neurology (2022)
67. Multiple Sclerosis Disease-Modifying Therapies and Covid-19 Vaccines: A Practical Review and Meta-Analysis, Journal of Neurology, Neurosurgery and Psychiatry (2022)
68. Myoclonic Dystonia (Dyt11) Responsive to Lacosamide: A Case Report, Acta Neurologica Belgica (2022)
69. N-Methyl-D-Aspartate (Nmda)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective, Mini-Reviews in Medicinal Chemistry (2022)
70. N-Methyl-D-Aspartate (Nmda)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective, Mini-Reviews in Medicinal Chemistry (2022)
71. Revisiting the Antiviral Theory to Explain Interferon-Beta's Effectiveness for Relapsing Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
72. Risk Factors of Severe Covid-19 in People With Multiple Sclerosis : A Systematic Review and Meta-Analysis, Revue Neurologique (2022)
73. Sars-Cov-2 Serology Among People With Multiple Sclerosis on Disease-Modifying Therapies After Bbibp-Corv (Sinopharm) Inactivated Virus Vaccination: Same Story, Different Vaccine, Multiple Sclerosis and Related Disorders (2022)
74. Self-Reported Safety of the Bbibp-Corv (Sinopharm) Covid-19 Vaccine Among Iranian People With Multiple Sclerosis, Human Vaccines and Immunotherapeutics (2022)
75. Significant Modulations of Linc001128 and Linc0938 With Mir-24-3P and Mir-30C-5P in Parkinson Disease, Scientific Reports (2022)
76. Sound-Specific Lingual Dystonia, Movement Disorders Clinical Practice (2022)
77. Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and Neuromyelitis Optica in a Patient, Case Reports in Immunology (2022)
78. Two Cousins With Acute Hemichorea After Bbibp-Corv (Sinopharm) Covid-19 Vaccine, Movement Disorders (2022)
79. Validity and Reliability of Persian Version of the Arm Function in Multiple Sclerosis Questionnaire, British Journal of Occupational Therapy (2022)
80. Acute Relapse and Poor Immunization Following Covid-19 Vaccination in a Rituximab-Treated Multiple Sclerosis Patient, Human Vaccines and Immunotherapeutics (2021)
81. Atypical Parkinsonism and Self-Mutilation: A New Lens on the Old Concept, Clinical Case Reports (2021)
82. Can Covid-19 Accelerate Neurodegeneration?, Clinical Case Reports (2021)
83. Conus Medullaris Involvement in Demyelinating Disorders of the Cns: A Comparative Study, Multiple Sclerosis and Related Disorders (2021)
84. Covid-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight With No Bystander Effect?, Multiple Sclerosis and Related Disorders (2021)
85. Epidemiological and Clinical Features of Pediatric-Onset Multiple Sclerosis: A Population-Based Study in Isfahan, Iran, Between 1997-2020, Current Journal of Neurology (2021)
86. Evaluation of Matrix Metalloproteinase-9 Plasma Levels in Untreated New Relapsing–Remitting Multiple Sclerosis Patients and Their First-Degree Family, Metabolic Brain Disease (2021)
87. Explaining the Facilitators of Quality of Life in Patients With Multiple Sclerosis: A Qualitative Study, BMC Neurology (2021)
88. Movement Disorders Associated With Covid-19, Parkinson's Disease (2021)
89. Mri Signs of Cns Demyelinating Diseases, Multiple Sclerosis and Related Disorders (2021)
90. Multiple Sclerosis Epidemiology in Asia and Oceania; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
91. Myasthenia Gravis and Coronavirus Disease 2019: A Report From Iran, Current Journal of Neurology (2021)
92. Outcome of Covid-19 Infection in Multiple Sclerosis Patients Receiving Disease-Modifying Therapies, Journal of Research in Medical Sciences (2021)
93. Parkinson's Disease Patients May Have Higher Rates of Covid-19 Mortality in Iran, Parkinsonism and Related Disorders (2021)
94. Prevalence of Coronavirus Disease 2019 in Patients With Neuromyelitis Optica in Isfahan, Iran, and a Review on Recent Reports and Literature, Current Journal of Neurology (2021)
95. Rituximab Induced Cytokine Release Syndrome in an Ms Patient: A Case Report, Clinical Case Reports (2021)
96. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
97. Safety and Efficacy of Fingolimod in Iranian Patients With Relapsing-Remitting Multiple Sclerosis: An Open-Label Study, Caspian Journal of Internal Medicine (2021)
98. Seizure Incidence Among Neuromyelitis Optica Spectrum Disorder Patients, Revue Neurologique (2021)
99. Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study, Movement Disorders (2021)
100. Surgical Left Atrial Appendage Closure: Success Rate and Its Relationship With Cerebrovascular Accident, Current Journal of Neurology (2021)
101. The Effect of Counseling Based on the Plissit Model on Sexual Quality of Life of Married Women With Multiple Sclerosis Referring to Ms Center in 2019: A Randomized, Controlled Trial, Archives of Women's Mental Health (2021)
102. The Effect of Ifn-Β Treatment on Plasma Levels of Bdnf and Il-6 in Relapsing-Remitting Multiple Sclerosis Patients, NeuroImmunoModulation (2021)
103. “Nmda Receptor Spectrum Disorder” in the Differential Diagnosis of Demyelinating Disorders of the Cns: Optic Neuritis and Myelitis, Neurological Sciences (2021)
104. A Compound Downregulation of Srrm2 and Mir-27A-3P With Upregulation of Mir-27B-3P in Pbmcs of Parkinson’S Patients Is Associated With the Early Stage Onset of Disease, PLoS ONE (2020)
105. Clinical Outcomes of Transverse Myelitis With Myelin Oligodendrocyte Glycoprotein Antibody Versus Negative Cases Among Adults in Isfahan, Iran: A Comparative Study, Current Journal of Neurology (2020)
106. Clinical Outcomes of Transverse Myelitis With Myelin Oligodendrocyte Glycoprotein Antibody Versus Negative Cases Among Adults in Isfahan, Iran: A Comparative Study, Current Journal of Neurology (2020)
107. Dorsal Midbrain Involvement in Mri As a Core Clinical Manifestation for Nmosd Diagnosis, Multiple Sclerosis and Related Disorders (2020)
108. Evaluating the Effectiveness of Cognitive Rehabilitation on Everyday Memory in Multiple Sclerosis Patients, Neuropsychological Rehabilitation (2020)
109. Evaluation of Plasma Osteopontin Level in Relapsing- Remitting Multiple Sclerosis Patients Compared to Healthy Subjects in Isfahan Province, International Journal of Neuroscience (2020)
110. Evaluation of Plasma Soluble Cd137 Level in Relapsing-Remitting Multiple Sclerosis Patients in Comparison With Healthy Controls in Isfahan Province, Iran, Neurology Asia (2020)
111. Fulminant Encephalitis As a Sole Manifestation of Covid-19, Neurological Sciences (2020)
112. High-Resolution Melting Curve Analysis of Polymorphisms Within Cd58, Cd226, Hla-G Genes and Association With Multiple Sclerosis Susceptibility in a Subset of Iranian Population: A Case–Control Study, Acta Neurologica Belgica (2020)
113. Incidence and Prevalence of Multiple Sclerosis in Persian Gulf Area: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2020)
114. Incidence of Anxiety in Epilepsy During Coronavirus Disease (Covid-19) Pandemic, Epilepsy and Behavior (2020)
115. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (Covid-19) Pandemic, Movement Disorders (2020)
116. Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis, Current Medicinal Chemistry (2020)
117. Potential Biomarker and Therapeutic Lncrnas in Multiple Sclerosis Through Targeting Memory B Cells, NeuroMolecular Medicine (2020)
118. The Effect of an Emotional Intelligence Component Program on Happiness in Patients With Epilepsy, Epilepsy and Behavior (2020)
119. The Effect of Fampridine on the Risk of Seizure in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2020)
120. The Effect of Total Body Resistance Exercise on Mobility, Proprioception, and Muscle Strength of the Knee in People With Multiple Sclerosis, Journal of Sport Rehabilitation (2020)
121. The Higher Prevalence of Multiple Sclerosis Among Iranian Georgians; New Clues to the Role of Genetic Factors, Revue Neurologique (2020)
122. The Higher Prevalence of Multiple Sclerosis Among Iranian Georgians; New Clues to the Role of Genetic Factors, Revue Neurologique (2020)
123. Acute Vision Loss in Multiple Sclerosis: Optic Neuritis or Central Serous Chorioretinopathy?, Multiple Sclerosis and Related Disorders (2019)
124. Anti-Hsv-2 Antibody in Patients With Ms and Nmo, Multiple Sclerosis and Related Disorders (2019)
125. Comparing Myelin Oligodendrocyte Glycoprotein Antibody (Mog-Ab) and Non Mog-Ab Associated Optic Neuritis: Clinical Course and Treatment Outcome, Multiple Sclerosis and Related Disorders (2019)
126. Complete Horizontal Gaze Palsy Due to Bilateral Paramedian Pontine Reticular Formation Involvement As a Presentation of Multiple Sclerosis: A Case Report, BMC Neurology (2019)
127. Coping Strategies and Their Relationship With Emotional Intelligence in Patients With Epilepsy Referred to Isfahan Epilepsy Society in 2017, Epilepsy and Behavior (2019)
128. Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis, Acta Medica Iranica (2019)
129. Increased Expression of Lymphocyte Activation Gene-3 by Regulatory T Cells in Multiple Sclerosis Patients With Fingolimod Treatment; [Multiple Sikleroz Hastalarinda Fingolimod Tedavisi Sonucu Duzenleyici T Hucrelerinde Lenfosit Aktivasyon Gen-3 Ekspresyonunda Artis], Turkish Journal of Immunology (2019)
130. Interleukin 18 Polymorphisms and Its Serum Level in Patients With Multiple Sclerosis, Annals of Indian Academy of Neurology (2019)
131. Lncrnas Associated With Multiple Sclerosis Expressed in the Th1 Cell Lineage, Journal of Cellular Physiology (2019)
132. Motor Neuron Diseases Caused by a Novel Vrk1 Variant – a Genotype/Phenotype Study, Annals of Clinical and Translational Neurology (2019)
133. Negative Regulation of Semaphorin-3A Expression in Peripheral Blood Mononuclear Cells Using Microrna-497-5P, Iranian Journal of Medical Sciences (2019)
134. Paraneoplastic Neuromyelitis Optica Associated With Fever of Unknown Origin As an Early Manifestation: A Case Report, Multiple Sclerosis and Related Disorders (2019)
135. Research Paper: The Association Between Salt and Potassium Intake With Multiple Sclerosis, Caspian Journal of Neurological Sciences (2019)
136. Serum Level of Interleukin 12 in Patients With Multiple Sclerosis, International Journal of Neuroscience (2019)
137. The Frequency of Varicella-Zoster Virus Infection in Patients With Multiple Sclerosis Receiving Fingolimod, Journal of Neuroimmunology (2019)
138. The Relationship Between Cognitive Disorders and Hippocampal Angle in Patients Multiple Sclerosis, Journal of Isfahan Medical School (2019)
139. Analysis of the Expression of Mir-34A, Mir-199A, Mir-30C and Mir-19A in Peripheral Blood Cd4+T Lymphocytes of Relapsing-Remitting Multiple Sclerosis Patients, Gene (2018)
140. Applying the 2017 Mcdonald Diagnostic Criteria for Multiple Sclerosis, The Lancet Neurology (2018)
141. Hla-G Gene Polymorphism and Soluble Hla-G Serum Level in Patients With Multiple Sclerosis, APMIS (2018)
142. Integrative Analysis of Lncrnas in Th17 Cell Lineage to Discover New Potential Biomarkers and Therapeutic Targets in Autoimmune Diseases, Molecular Therapy Nucleic Acids (2018)
143. Interleukin-10 and Brain-Derived Neurotrophic Factor Responses to the Mat Pilates Training in Women With Multiple Sclerosis, Scientia Medica (2018)
144. Investigating the Occurrence of Femoral Head Avascular Necrosis in Patient With Multiple Sclerosis Treated With Interferon-Beta, Journal of Isfahan Medical School (2018)
145. Investigation of Erg Gene Expression in Iranian Patients With Multiple Sclerosis, Immunological Investigations (2018)
146. Memory Rehabilitation for the Working Memory of Patients With Multiple Sclerosis (Ms), Journal of Clinical and Experimental Neuropsychology (2018)
147. Patient Preferences for Interferon-Beta in Iran: A Discrete Choice Experiment, PLoS ONE (2018)
148. Risk Factor Effect of Rs1044165 and Rs3745453 As Neighboring Variants of Mir-223, Mir-24, Mir-23A and Mir-27A on the Onset of Ms Disease in Isfahan/Iran, Gene Reports (2018)
149. Semaphorin-3A As an Immune Modulator Is Suppressed by Microrna-145-5P, Cell Journal (2018)
150. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
151. Serum Levels of 25(Oh) Vitamin D3 and Clinical Manifestation of First Demyelinating Attack, Journal of Isfahan Medical School (2018)
152. The Levels of Soluble Forms of Cd21 and Cd83 in Multiple Sclerosis, Journal of Neuroimmunology (2018)
153. A Case-Control Study on Risk Factors in Pediatric Multiple Sclerosis Population, Isfahan Province, Iran: Highlighting the Role of Puberty, Journal of Isfahan Medical School (2017)
154. Anti‑Ma2 Receptor Encephalitis Mimicking Huntington Chorea, Journal of Research in Medical Sciences (2017)
155. Cancer Risk Among Patients With Multiple Sclerosis: A Cohort Study in Isfahan, Iran, Caspian Journal of Internal Medicine (2017)
156. Cd25 Gene Polymorphism and Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2017)
157. Cytomegalovirus and Varicella Zoster Virus Seropositivity of Iranian Patients With Multiple Sclerosis: A Population-Based Study, Journal of Neuroimmunology (2017)
158. Decreased Expression of Sema3a, an Immune Modulator, in Blood Sample of Multiple Sclerosis Patients, Gene (2017)
159. Efficacy and Safety of Rituximab in Neuromyelitis Optica: Review of Evidence, Journal of Research in Medical Sciences (2017)
160. Interleukin-33 Plasma Levels in Patients With Relapsing-Remitting Multiple Sclerosis, Biomolecular Concepts (2017)
161. Multiple Sclerosis Among Afghan Immigrants in Isfahan, Iran, Multiple Sclerosis and Related Disorders (2017)
162. Statistical Support for Sema3a and Multiple Sclerosis, Gene (2017)
163. The +4259A>C Polymorphism of Tim-3 But Not -1637C>T Polymorphism of Tim-1 Is Associated With Multiple Sclerosis in Isfahan Population, Multiple Sclerosis and Related Disorders (2017)
164. An Investigation Into the Association Between Hla-G 14Bp Insertion/Deletion Polymorphism and Multiple Sclerosis Susceptibility, Journal of Neuroimmunology (2016)
165. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province, International Journal of Preventive Medicine (2016)
166. Association of Tim-1 5383-5397Ins/Del and Tim-3 -1541C>T Polymorphisms With Multiple Sclerosis in Isfahan Population, International Journal of Immunogenetics (2016)
167. Bio-Accumulation of Some Heavy Metals in Blood Serum of Residents in Isfahan and Shiraz, Iran, Environmental Monitoring and Assessment (2016)
168. Comparison of Energy Consumption in Different Clinical Forms Multiple Sclerosis With Normal Subjects (Cohort Study), Multiple Sclerosis and Related Disorders (2016)
169. Corrigendum to an Investigation Into the Association Between Hla-G 14 Bp Insertion/Deletion Polymorphism and Multiple Sclerosis Susceptibility [Journal of Neuroimmunology 290 (2016) 115-118] Doi 10.1016/J.Jneuroim.2015.11.019, Journal of Neuroimmunology (2016)
170. Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients, Journal of Child Neurology (2016)
171. Effects of Prolonged Fasting on Fatigue and Quality of Life in Patients With Multiple Sclerosis, Neurological Sciences (2016)
172. Efficacy of Adding Vitamin D Supplementation to Interferon Β-1 in Multiple Sclerosis, Journal of Isfahan Medical School (2016)
173. Evaluation of Lymphocyte Activation Gene3 (Lag-3) on Regulatory T Cells in Patients With Multiple Sclerosis by Intervention Effect of Fingolimod, Journal of Isfahan Medical School (2016)
174. Evaluation of the Frequency of Osteopontin Gene Polymorphism (Rs28357094 T>G) and Its Receptor Gene (Itga4- Rs1449263 A>G) in Multiple Sclerosis Patients in Comparison to Healthy Controls in Isfahan, Iran, Population, Journal of Isfahan Medical School (2016)
175. Il-27 Plasma Level in Relapsing Remitting Multiple Sclerosis Subjects: The Double-Faced Cytokine, Journal of Immunoassay and Immunochemistry (2016)
176. Iranian Consensus on Use of Vitamin D in Patients With Multiple Sclerosis, BMC Neurology (2016)
177. Iranian Consensus on Use of Vitamin D in Patients With Multiple Sclerosis, BMC Neurology (2016)
178. Mannose-Binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders, Iranian Journal of Allergy, Asthma and Immunology (2016)
179. Prevalence of Cryptosporidium Infection in Patients With Multiple Sclerosis Compared to Control Group in Isfahan City, Iran, Journal of Isfahan Medical School (2016)
180. Prevalence of Hypothyroidism Among Patients With Multiple Sclerosis Referred to Multiple Sclerosis Clinic of Alzahra Hospital, Isfahan, Iran, During 2014-2015, Journal of Isfahan Medical School (2016)
181. Prevalence of Multiple Sclerosis in Iranian Emigrants: Review of the Evidence, Neurological Sciences (2016)
182. Prevalence of Multiple Sclerosis in Iranian Emigrants: Review of the Evidence, Neurological Sciences (2016)
183. Risk Factors of Early Onset of Ms in Women in Reproductive Age Period: Survival Analysis Approach, Archives of Women's Mental Health (2016)
184. Soil Heavy Metals Are Associated With the Distribution of Multiple Sclerosis in Isfahan, Iran, Acta Neurologica Scandinavica (2016)
185. The Effects of Motivational Interviewing on Health Promoting Behaviors of Patients With Multiple Sclerosis, Iranian Journal of Nursing and Midwifery Research (2016)
186. The Outbreak Fingolimod Cardiovascular Side Effects in Relapsing-Remitting Multiple Sclerosis Patient: A Longitudinal Study in an Iranian Population, ARYA Atherosclerosis (2016)
187. Upregulation of Cd4+ T-Cell Derived Mir-223 in the Relapsing Phase of Multiple Sclerosis Patients, Cell Journal (2016)
188. A Comparison of Linear and Nonlinear Stability Parameters in Different Clinical Forms of Multiple Sclerosis, European Review of Aging and Physical Activity (2015)
189. Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2015)
190. Amyotrophic Lateral Sclerosis Progression: Iran-Als Clinical Registry, a Multicentre Study, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2015)
191. Comparing the Frequency of Tim-3 Polymorphism in Multiple Sclerosis Patients With Healthy Controls, Journal of Isfahan Medical School (2015)
192. Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients, International Journal of Preventive Medicine (2015)
193. Effects of Vitamin D on Retinal Nerve Fiber Layer in Vitamin D Deficient Patients With Optic Neuritis: Preliminary Findings of a Randomized, Placebo-Controlled Trial, Journal of Research in Medical Sciences (2015)
194. Effects of Whole Body Vibration on Hormonal & Functional Indices in Patients With Multiple Sclerosis, Indian Journal of Medical Research (2015)
195. Erratum: Inflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis (Rrms) Patients (Multiple Sclerosis and Related Disorders (2014) 3 (741) Doi: 10.1016/J.Msard.2014.09.158), Multiple Sclerosis and Related Disorders (2015)
196. Evaluation of Soluble Human Leukocyte Antigen-G (Shla-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2015)
197. Il-23 Plasma Level Measurement in Relapsing Remitting Multiple Sclerosis (Rrms) Patients Compared to Healthy Subjects, Immunological Investigations (2015)
198. Increased Serum Level of Il-37 in Patients With Multiple Sclerosis and Neuromyelitis Optica, Acta Neurologica Belgica (2015)
199. Mir-141 and Mir-200A, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis, PLoS ONE (2015)
200. Multiple Sclerosis and Hyperprolactinemia: A Case–Control Study, Acta Neurologica Belgica (2015)
201. The Beneficial Effects of Vitamin D3 on Reducing Antibody Titers Against Epstein-Barr Virus in Multiple Sclerosis Patients, Cellular Immunology (2015)
202. The Distinctive Contrast of Multiple Sclerosis Epidemiology Between Persians and Armenian Minority Community of Isfahan City, Iran, Neurological Sciences (2015)
203. The Epidemiologic and Demographic Characteristics and Clinical Findings in Patients With Acute Disseminated Encephalomyelitis (Adem) Referred to Alzahra Hospital, Isfahan, Iran, During 10 Years (2003-2013), Journal of Isfahan Medical School (2015)
204. The Frequency of Tim-3-1541C>T Polymorphisms and Its Association With Multiple Sclerosis, Journal of Isfahan Medical School (2015)
205. Tnf-Alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls, Immunological Investigations (2015)
206. An Epidemiological Study of Neuromyelitis Optica in Isfahan, Multiple Sclerosis Journal (2014)
207. Characteristics of Familial Multiple Sclerosis in Isfahan, Iran: A Cross-Sectional Study, Neurology Asia (2014)
208. Conversion From Radiologically Isolated Syndrome to Multiple Sclerosis, International Journal of Preventive Medicine (2014)
209. Effects of Resistance Training and Vibration on Hormonal Changes in Female Patients With Multiple Sclerosis, Neurology Asia (2014)
210. Estimated Prevalence and Incidence of Multiple Sclerosis in Iran, European Neurology (2014)
211. Frequency of Blood-Tissue Parasitic Infections in Patients With Multiple Sclerosis, As Compared to Their Family Members, International Journal of Preventive Medicine (2014)
212. Islamic Fasting and Multiple Sclerosis, BMC Neurology (2014)
213. Leptin Hormone Level in Serum of Opticospinal, Neuromyelitisoptica and Multiple Sclerosis Patients, Clinical and Experimental Neuroimmunology (2014)
214. Mir-326 and Mir-26A, Two Potential Markers for Diagnosis of Relapse and Remission Phases in Patient With Relapsing-Remitting Multiple Sclerosis, Gene (2014)
215. Multiple Sclerosis in Isfahan, Iran: An Update, Multiple Sclerosis Journal (2014)
216. Safety and Efficacy of Mitoxantrone in Pediatric Patients With Aggressive Multiple Sclerosis, European Journal of Paediatric Neurology (2014)
217. The Relationship of Concentrations of Lead and Zinc and Multiple Sclerosis in Isfahan Province, Iran, Journal of Isfahan Medical School (2014)
218. The Role of Information System in Multiple Sclerosis Management, Journal of Research in Medical Sciences (2014)
219. Can Vitamin D Suppress Endothelial Cells Apoptosis in Multiple Sclerosis Patients?, International Journal of Preventive Medicine (2013)
220. Circadian Rhythm Sleep Disorders in Patients With Multiple Sclerosis and Its Association With Fatigue: A Case-Control Study, Journal of Research in Medical Sciences (2013)
221. Does Levetircetam Decrease of the Rubral Tremor in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
222. Effects of Topiramate on Afferent Visual Pathways: Controversies and Uncertainties, Neurological Sciences (2013)
223. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
224. Epileptic Seizures in Multiple Sclerosis: A Population-Based Survey in Iran, Acta Neurologica Belgica (2013)
225. Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized, Placebo-Controlled, Double-Blind Pilot Study, International Journal of Neuroscience (2013)
226. Is It Necessary to Perform Connective Tissue Disorders Laboratory Tests When a Patient Experiences the First Demyelinating Attack?, Journal of Research in Medical Sciences (2013)
227. Multiple Sclerosis Among Iranian-Arabs and Persians of Khuzestan: Is There Any Ethnic Difference?, Clinical Neurology and Neurosurgery (2013)
228. Necrotizing External Otitis: A Case Series, B-ENT (2013)
229. Neurosarcoidosis: Clinical Features, Diagnosis, and Management, American Journal of Therapeutics (2013)
230. Pediatric Multiple Sclerosis With Primary Progressive Course-Report of a Retrospective Cohort Study in Iran, Neuropediatrics (2013)
231. Preventive Effect of Vitamin D3 Supplementation on Conversion of Optic Neuritis to Clinically Definite Multiple Sclerosis: A Double Blind, Randomized, Placebo-Controlled Pilot Clinical Trial, Acta Neurologica Belgica (2013)
232. Vitamin D: Shining a Light on Clinical and Sex Specific Effects in Multiple Sclerosis?, International Journal of Preventive Medicine (2013)
233. 25-Hydroxyvitamin D Concentrations in Patients With Optic Neuritis As a Clinically Isolated Syndrome and Healthy Controls, International Journal of Preventive Medicine (2012)
234. Anti-Aquaporin-4 Igg in Patients Presenting With Unilateral Optic Neuritis: A Cohort Study, International Journal of Preventive Medicine (2012)
235. Association of Urodynamic Findings in New Onset Multiple Sclerosis With Subsequent Occurrence of Urinary Symptoms and Acute Episode of Disease in Females, Journal of Research in Medical Sciences (2012)
236. Better Prognosis of Multiple Sclerosis in Patients Who Experienced a Full-Term Pregnancy, European Neurology (2012)
237. Cesarean Delivery May Increase the Risk of Multiple Sclerosis, Multiple Sclerosis Journal (2012)
238. Combination Therapy With Mitoxantrone and Plasma Exchange in Aggressive Relapsing Remitting Multiple Sclerosis: A Preliminary Clinical Study, Journal of Research in Medical Sciences (2012)
239. Comparison of the Efficacy and Side Effects of Ifn Beta 1-A (Rebif) and a Biosimilar Product (Recigen) in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2012)
240. Effect of Aquatic Exercise Training on Fatigue and Health-Related Quality of Life in Patients With Multiple Sclerosis, Archives of Physical Medicine and Rehabilitation (2012)
241. Epileptic Seizures in Early-Onset Multiple Sclerosis, Archives of Iranian Medicine (2012)
242. Fatigue, Depression, and Health-Related Quality of Life in Patients With Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2012)
243. Headache in Migraine Patients Receiving Topiramate: A Mere Migraine Attack or a Harbinger of Ciliochoroidal Effusion Syndrome?, Acta Neurologica Belgica (2012)
244. Hemiballismus, Hyperphagia, and Behavioral Changes Following Subthalamic Infarct, Case Reports in Medicine (2012)
245. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)
246. Interferon-Beta-1Beta Protects Against Multiple Sclerosis-Induced Endothelial Cells Apoptosis, Frontiers in Bioscience - Elite (2012)
247. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
248. Linkage of Multiple Sclerosis and Guillain-Barre Syndrome: A Population-Based Survey in Isfahan, Iran, Autoimmune Diseases (2012)
249. Multiple Sclerosis and Amyotrophic Lateral Sclerosis: Is There a Link?, Multiple Sclerosis Journal (2012)
250. Multiple Sclerosis in Isfahan, Iran: Past, Present and Future, International Journal of Preventive Medicine (2012)
251. Seroprevalence of Nmo-Igg Among Patients With Neuromyelitis Optica and Opticospinal Multiple Sclerosis, Clinical Neurology and Neurosurgery (2012)
252. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
253. Topiramate and the Vision: A Systematic Review, Clinical Ophthalmology (2012)
254. Assessing the Impact of Menstrual Cycle in Incidence of Symptoms of Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2011)
255. Cigarette Smoking and the Risk of Multiple Sclerosis: A Sibling Case-Control Study in Isfahan, Iran, Neuroepidemiology (2011)
256. Complement in Neurobiology, Frontiers in Bioscience (2011)
257. Effects of Yoga on Depression in Women With Multiple Sclerosis, Journal of Isfahan Medical School (2011)
258. Epstein-Barr Virus and Multiple Sclerosis: Wrong Place, Wrong Time?, Neuroinflammation (2011)
259. Features of Virchow-Robin Spaces in Newly Diagnosed Multiple Sclerosis Patients, European Journal of Radiology (2011)
260. Frequency of Isolated Ocular Motor Nerves Palsy in Patients With Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
261. Intrinsic Third Ventricular Craniopharyngioma: A Case Report, International Journal of Preventive Medicine (2011)
262. Myasthenia Gravis During the Course of Neuromyelitis Optica, Case Reports in Neurology (2011)
263. Mycophenolate Mofetil in Combination With Interferon Beta-1A in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Preliminary Study, Journal of Research in Medical Sciences (2011)
264. Number and Volume of Demyelinative Plaques Can Predict the Response to Treatment in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2011)
265. Pregnancy and Multiple Sclerosis, Neurological Disorders and Pregnancy (2011)
266. Rapid Exacerbation of Multiple Sclerosis Following the Initiation of Interferon-Β: Report of Nine Cases, Journal of Research in Medical Sciences (2011)
267. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
268. The Compartive Study of Prevalence of Ulcerative Colitis in General Population With Ms Patients, Journal of Isfahan Medical School (2011)
269. The Study of Circadian Rhythms Disorder and Its Relationship With Chronic Fatigue in Multiple Sclerosis in Compare With Control Group, Journal of Isfahan Medical School (2011)
270. Torque Teno Mini Virus Infection and Multiple Sclerosis, International Journal of Neuroscience (2011)
271. Transverse Myelitis, Neuroinflammation (2011)
272. Viral Pathophysiology of Multiple Sclerosis: A Role for Epstein-Barr Virus Infection?, Pathophysiology (2011)
273. A Report of Multiple Sclerosis Patients Treated by Cinnovex™ in Iran, Tehran University Medical Journal (2010)
274. Associated Factors With Swallowing Disorders in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2010)
275. Concentrations of Nitric Oxide Metabolites in the Serum of Iranian Multiple Sclerosis Patients, Journal of the Neurological Sciences (2010)
276. Epidemiology of Amyotrophic Lateral Sclerosis in Isfahan, Iran, European Journal of Neurology (2010)
277. Female Hormones and Multiple Sclerosis, Women and Multiple Sclerosis (2010)
278. Increasing Female Preponderance of Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2010)
279. Oropharyngeal Dysphagia in Multiple Sclerosis, Multiple Sclerosis (2010)
280. Pregnancy and Multiple Sclerosis, Neurological Disorders and Pregnancy (2010)
281. Role of Platelets in Neuroinflammation: A Wide-Angle Perspective, Journal of Neuroinflammation (2010)
282. Antiphospholipid Antibodies: Paradigm in Transition, Journal of Neuroinflammation (2009)
283. Cavernous Angioma: A Clinical Study of 35 Cases With Review of the Literature, Neurological Research (2009)
284. Comparing Side Effects of Cinnovex With Avonex in Relapsing Remitting Multiple Sclerosis Patients, Journal of Isfahan Medical School (2009)
285. Frequency of Myasthenia Gravis in Multiple Sclerosis: Report of Five Cases From Isfahan, Iran, Neurology India (2009)
286. Multiple Sclerosis and Neurofibromatosis Type 1: Report of Seven Patients From Iran, Multiple Sclerosis (2009)
287. Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies, Future Neurology (2009)
288. Short-Term Effects of Prolonged Fasting on Multiple Sclerosis, European Neurology (2009)
289. Association of Cd24v/V Genotype With Susceptibility and Progression of Multiple Sclerosis in Iranian Population, Iranian Journal of Biotechnology (2008)
290. Efficacy of Gabapentin in the Treatment of Sunct Syndrome, Cephalalgia (2008)
291. How Frequent Is Celiac Disease Among Epileptic Patients?, Journal of Gastrointestinal and Liver Diseases (2008)
292. Television-Provoked Epilepsy in Children: A Follow-Up Survey From Isfahan, Iran, Archives of Iranian Medicine (2008)
293. Childhood-Onset Multiple Sclerosis: Report of 82 Patients From Isfahan, Iran, Archives of Iranian Medicine (2007)
294. Clinical and Demographical Characteristics of Primary Progressive Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2007)
295. Comparison of Interferon Beta Products and Azathioprine in the Treatment of Relapsing-Remitting Multiple Sclerosis, Journal of Neurology (2007)
296. Conjugal Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2007)
297. Mitoxantrone Reduced Disability in Iranian Patients With Multiple Sclerosis, Archives of Iranian Medicine (2007)
298. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
299. Orthostatic Hypotension in Iranian Patients With Parkinson's Disease, Neurosciences (2007)
300. Comparison of Betaferon, Avonex, and Rebif in Treatment of Relapsing-Remitting Multiple Sclerosis, Acta Neurologica Scandinavica (2006)
301. Early Onset Cardiotoxicity Associated With Mitoxantrone in Patients With Multiple Sclerosis, Neurosciences (2006)
302. Mitoxantrone-Induced Cardiotoxicity in Patients With Multiple Sclerosis, Archives of Iranian Medicine (2006)
303. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
304. Spectrophotometry of Cerebrospinal Fluid May Facilitate the Diagnosis in Neurological Patients [1], Journal of Research in Medical Sciences (2006)
305. Distribution by Location of Ct-Diagnosed Primary Intracerebral Hemorrhage in Isfahan, Journal of Research in Medical Sciences (2005)
306. The Preventive Role of Topical Timolol in Treatment of Migraine Headaches, Journal of Research in Medical Sciences (2005)
307. Neurological Manifestations of Allgrove Syndrome, Archives of Iranian Medicine (2004)